title: [Drug Rash with Eosinophilia and Systemic Symptoms syndrome induced by telaprevir in a patient with chronic hepatitis C virus infection].
authors.affiliation: Servicio de Aparato Digestivo, Hospital Universitario de La Princesa, Madrid, España; CIBEREHD (Instituto de Salud Carlos III), Instituto de Investigación Sanitaria Princesa (IIS-IP), Universidad Autónoma de Madrid, Madrid, España. Electronic address: veronicamartin29@yahoo.es.
authors.forename: Verónica
authors.initials: V
authors.lastname: Martín Domínguez
authors.affiliation: Servicio de Dermatología, Hospital Universitario de La Princesa, Madrid, España.
authors.forename: Raquel
authors.initials: R
authors.lastname: Carrascosa de Lome
authors.affiliation: Servicio de Aparato Digestivo, Hospital Universitario de La Princesa, Madrid, España.
authors.forename: Irene
authors.initials: I
authors.lastname: Becerro González
authors.affiliation: Servicio de Dermatología, Hospital Universitario de La Princesa, Madrid, España.
authors.forename: Diego
authors.initials: D
authors.lastname: de Argila
authors.affiliation: Servicio de Anatomía Patológica, Hospital Universitario de La Princesa, Madrid, España.
authors.forename: Karen
authors.initials: K
authors.lastname: Villar
authors.affiliation: Servicio de Aparato Digestivo, Hospital Universitario de La Princesa, Madrid, España; CIBEREHD (Instituto de Salud Carlos III), Instituto de Investigación Sanitaria Princesa (IIS-IP), Universidad Autónoma de Madrid, Madrid, España.
authors.forename: L
authors.initials: L
authors.lastname: García-Buey
mesh_terms: D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000998:Antiviral Agents / Q000009:adverse effects* / Q000627:therapeutic use; D063926:Drug Hypersensitivity Syndrome / Q000188:drug therapy / Q000209:etiology*; D004359:Drug Therapy, Combination; D019698:Hepatitis C, Chronic / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D007372:Interferons / Q000627:therapeutic use; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D009842:Oligopeptides / Q000009:adverse effects* / Q000627:therapeutic use; D011092:Polyethylene Glycols / Q000627:therapeutic use; D011480:Protease Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D011994:Recombinant Proteins / Q000627:therapeutic use; D012254:Ribavirin / Q000627:therapeutic use
chemical_list: D000893:Anti-Inflammatory Agents; D000998:Antiviral Agents; D009842:Oligopeptides; D011480:Protease Inhibitors; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D012254:Ribavirin; C486464:telaprevir; D007372:Interferons; D008775:Methylprednisolone